Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1299)	6/3/1999 9:46:00 AM
From: Thure Meyer	Read Replies (1) \| Respond to of 1837

Check out the Yahoo board. Some smart people there and intelligent comments about the patent. Thure

To: vestor who wrote (1299)	6/4/1999 8:08:00 AM
From: harkenman	Read Replies (1) \| Respond to of 1837

Based on Cenestin NDA approval I would say 1 to 2 months. <<Any idea how close DRMD is to getting approval for the ANDA birth control pill...... last I heard it was to be within weeks.... >> <<The patent grant is great news although it is differcult to measure from an investment point of view..... Is there anyone with the knowledge that can comment as to the financial impact this grant would have or should it just be considered an ingredient or step that leads to greater opportunities for the developement of NDA's ? >> Make company more sucestible to a buy out by major company such as JNJ. Also open new market based on Prempro Premphase prodcut for JNJ who has nothing in this area. <<Does the patent alone have monetary value? >> Only as potential future earnings. Increase companies value. Aslo makes compay more desirable for partnership/buyout. look at the Roche Genetech deal.